BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gobbetti T, Dalli J, Colas RA, Federici Canova D, Aursnes M, Bonnet D, Alric L, Vergnolle N, Deraison C, Hansen TV, Serhan CN, Perretti M. Protectin D1n-3 DPA and resolvin D5n-3 DPA are effectors of intestinal protection. Proc Natl Acad Sci U S A 2017;114:3963-8. [PMID: 28356517 DOI: 10.1073/pnas.1617290114] [Cited by in Crossref: 82] [Cited by in F6Publishing: 79] [Article Influence: 16.4] [Reference Citation Analysis]
Number Citing Articles
1 Flak MB, Colas RA, Muñoz-Atienza E, Curtis MA, Dalli J, Pitzalis C. Inflammatory arthritis disrupts gut resolution mechanisms, promoting barrier breakdown by Porphyromonas gingivalis. JCI Insight 2019;4:125191. [PMID: 31292292 DOI: 10.1172/jci.insight.125191] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 6.0] [Reference Citation Analysis]
2 Pistorius K, Souza PR, De Matteis R, Austin-Williams S, Primdahl KG, Vik A, Mazzacuva F, Colas RA, Marques RM, Hansen TV, Dalli J. PDn-3 DPA Pathway Regulates Human Monocyte Differentiation and Macrophage Function. Cell Chem Biol 2018;25:749-760.e9. [PMID: 29805036 DOI: 10.1016/j.chembiol.2018.04.017] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 7.5] [Reference Citation Analysis]
3 Sochal M, Mosińska P, Fichna J. Diagnostic value of chemerin in lower gastrointestinal diseases—a review. Peptides 2018;108:19-24. [DOI: 10.1016/j.peptides.2018.08.012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
4 Caër C, Wick MJ. Human Intestinal Mononuclear Phagocytes in Health and Inflammatory Bowel Disease. Front Immunol 2020;11:410. [PMID: 32256490 DOI: 10.3389/fimmu.2020.00410] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 10.0] [Reference Citation Analysis]
5 Sezin T, Ferreirós N, Jennrich M, Ochirbold K, Seutter M, Attah C, Mousavi S, Zillikens D, Geisslinger G, Sadik CD. 12/15-Lipoxygenase choreographs the resolution of IgG-mediated skin inflammation. Journal of Autoimmunity 2020;115:102528. [DOI: 10.1016/j.jaut.2020.102528] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Lee J, An J, Kim T, Ko Y, Park J, Oh D. Discovery and Engineering of a Microbial Double-Oxygenating Lipoxygenase for Synthesis of Dihydroxy Fatty Acids as Specialized Proresolving Mediators. ACS Sustainable Chem Eng 2020;8:16172-83. [DOI: 10.1021/acssuschemeng.0c04793] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
7 Camba-Gómez M, Gualillo O, Conde-Aranda J. New Perspectives in the Study of Intestinal Inflammation: Focus on the Resolution of Inflammation. Int J Mol Sci 2021;22:2605. [PMID: 33807591 DOI: 10.3390/ijms22052605] [Reference Citation Analysis]
8 Rosenthal MD, Brown CJ, Loftus TJ, Vanzant EL, Croft CA, Martindale RG. Nutritional Management and Strategies for the Enterocutaneous Fistula. Curr Surg Rep 2020;8. [DOI: 10.1007/s40137-020-00255-5] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
9 An JU, Kim SE, Oh DK. Molecular insights into lipoxygenases for biocatalytic synthesis of diverse lipid mediators. Prog Lipid Res 2021;83:101110. [PMID: 34144023 DOI: 10.1016/j.plipres.2021.101110] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Sønderskov J, Tungen JE, Palmas F, Dalli J, Serhan CN, Stenstrøm Y, Hansen TV. Stereoselective synthesis of MaR2n-3 DPA. Tetrahedron Lett 2020;61:151510. [PMID: 33273748 DOI: 10.1016/j.tetlet.2019.151510] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
11 Alhouayek M, Ameraoui H, Muccioli GG. Bioactive lipids in inflammatory bowel diseases - From pathophysiological alterations to therapeutic opportunities. Biochim Biophys Acta Mol Cell Biol Lipids 2021;1866:158854. [PMID: 33157277 DOI: 10.1016/j.bbalip.2020.158854] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
12 Nesman JI, Tungen JE, Vik A, Hansen TV. Stereoselective synthesis of the specialized pro-resolving and anti-inflammatory mediator resolvin E1. Tetrahedron 2020;76:130821. [DOI: 10.1016/j.tet.2019.130821] [Cited by in Crossref: 4] [Article Influence: 2.0] [Reference Citation Analysis]
13 Fosshaug LE, Colas RA, Anstensrud AK, Gregersen I, Nymo S, Sagen EL, Michelsen A, Vinge LE, Øie E, Gullestad L, Halvorsen B, Hansen TV, Aukrust P, Dalli J, Yndestad A. Early increase of specialized pro-resolving lipid mediators in patients with ST-elevation myocardial infarction. EBioMedicine 2019;46:264-73. [PMID: 31345784 DOI: 10.1016/j.ebiom.2019.07.024] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
14 Nishiumi S, Izumi Y, Yoshida M. Alterations in Docosahexaenoic Acid-Related Lipid Cascades in Inflammatory Bowel Disease Model Mice. Dig Dis Sci 2018;63:1485-96. [DOI: 10.1007/s10620-018-5025-4] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
15 Lamon-Fava S, So J, Mischoulon D, Ziegler TR, Dunlop BW, Kinkead B, Schettler PJ, Nierenberg AA, Felger JC, Maddipati KR, Fava M, Rapaport MH. Dose- and time-dependent increase in circulating anti-inflammatory and pro-resolving lipid mediators following eicosapentaenoic acid supplementation in patients with major depressive disorder and chronic inflammation. Prostaglandins Leukot Essent Fatty Acids 2021;164:102219. [PMID: 33316626 DOI: 10.1016/j.plefa.2020.102219] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
16 Ho GT, Cartwright JA, Thompson EJ, Bain CC, Rossi AG. Resolution of Inflammation and Gut Repair in IBD: Translational Steps Towards Complete Mucosal Healing. Inflamm Bowel Dis 2020;26:1131-43. [PMID: 32232386 DOI: 10.1093/ibd/izaa045] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 16.0] [Reference Citation Analysis]
17 Colby JK, Jaoude J, Liu F, Shureiqi I. Oxygenated lipid signaling in tumor-associated macrophages—focus on colon cancer. Cancer Metastasis Rev 2018;37:289-315. [DOI: 10.1007/s10555-018-9743-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
18 Caprara G. Mediterranean-Type Dietary Pattern and Physical Activity: The Winning Combination to Counteract the Rising Burden of Non-Communicable Diseases (NCDs). Nutrients 2021;13:429. [PMID: 33525638 DOI: 10.3390/nu13020429] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
19 Becker F, Romero E, Goetzmann J, Hasselschwert DL, Dray B, Vanchiere J, Fontenot J, Yun JW, Norris PC, White L, Musso M, Serhan CN, Alexander JS, Gavins FNE. Endogenous Specialized Proresolving Mediator Profiles in a Novel Experimental Model of Lymphatic Obstruction and Intestinal Inflammation in African Green Monkeys. Am J Pathol 2019;189:1953-72. [PMID: 31547920 DOI: 10.1016/j.ajpath.2019.05.013] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
20 Ishihara T, Yoshida M, Arita M. Omega-3 fatty acid-derived mediators that control inflammation and tissue homeostasis. International Immunology 2019;31:559-67. [DOI: 10.1093/intimm/dxz001] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 11.0] [Reference Citation Analysis]
21 Yang C, Qiao Z, Xu Z, Wang X, Deng Q, Chen W, Huang F. Algal Oil Rich in Docosahexaenoic Acid Alleviates Intestinal Inflammation Induced by Antibiotics Associated with the Modulation of the Gut Microbiome and Metabolome. J Agric Food Chem 2021;69:9124-36. [PMID: 33900083 DOI: 10.1021/acs.jafc.0c07323] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Tungen JE, Primdahl KG, Hansen TV. The First Total Synthesis of the Lipid Mediator PD2n-3 DPA. J Nat Prod 2020;83:2255-60. [PMID: 32543839 DOI: 10.1021/acs.jnatprod.0c00385] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
23 Onali S, Favale A, Fantini MC. The Resolution of Intestinal Inflammation: The Peace-Keeper's Perspective. Cells 2019;8:E344. [PMID: 30979024 DOI: 10.3390/cells8040344] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
24 Quirós M, Nusrat A. Contribution of Wound-Associated Cells and Mediators in Orchestrating Gastrointestinal Mucosal Wound Repair. Annu Rev Physiol 2019;81:189-209. [PMID: 30354933 DOI: 10.1146/annurev-physiol-020518-114504] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
25 Ungaro F, Rubbino F, Danese S, D'Alessio S. Actors and Factors in the Resolution of Intestinal Inflammation: Lipid Mediators As a New Approach to Therapy in Inflammatory Bowel Diseases. Front Immunol 2017;8:1331. [PMID: 29109724 DOI: 10.3389/fimmu.2017.01331] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 7.0] [Reference Citation Analysis]
26 Nesman JI, Chen O, Luo X, Ji RR, Serhan CN, Hansen TV. A new synthetic protectin D1 analog 3-oxa-PD1n-3 DPA reduces neuropathic pain and chronic itch in mice. Org Biomol Chem 2021;19:2744-52. [PMID: 33687402 DOI: 10.1039/d0ob02136a] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 Van Anh TT, Mostafa A, Rao Z, Pace S, Schwaiger S, Kretzer C, Temml V, Giesel C, Jordan PM, Bilancia R, Weinigel C, Rummler S, Waltenberger B, Hung T, Rossi A, Stuppner H, Werz O, Koeberle A. From Vietnamese plants to a biflavonoid that relieves inflammation by triggering the lipid mediator class switch to resolution. Acta Pharm Sin B 2021;11:1629-47. [PMID: 34221873 DOI: 10.1016/j.apsb.2021.04.011] [Reference Citation Analysis]
28 Xiang MS, Tan JK, Macia L. Fatty Acids, Gut Bacteria, and Immune Cell Function. The Molecular Nutrition of Fats. Elsevier; 2019. pp. 151-64. [DOI: 10.1016/b978-0-12-811297-7.00011-1] [Cited by in Crossref: 4] [Article Influence: 1.3] [Reference Citation Analysis]
29 Quiros M. Therapeutic Opportunities for Repair GPCRs during Intestinal Mucosal Wound Healing. Trends Mol Med 2020;26:971-4. [PMID: 32958405 DOI: 10.1016/j.molmed.2020.08.011] [Reference Citation Analysis]
30 Kikut J, Drozd A, Mokrzycka M, Grzybowska-chlebowczyk U, Ziętek M, Szczuko M. Are EPA and DHA Derivatives Involved in IBD Remission? JCM 2022;11:2388. [DOI: 10.3390/jcm11092388] [Reference Citation Analysis]
31 Nesman JI, Gangestad Primdahl K, Tungen JE, Palmas F, Dalli J, Hansen TV. Synthesis, Structural Confirmation, and Biosynthesis of 22-OH-PD1n-3 DPA. Molecules 2019;24:E3228. [PMID: 31491851 DOI: 10.3390/molecules24183228] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
32 Hagihara M, Kuroki Y, Ariyoshi T, Higashi S, Fukuda K, Yamashita R, Matsumoto A, Mori T, Mimura K, Yamaguchi N, Okada S, Nonogaki T, Ogawa T, Iwasaki K, Tomono S, Asai N, Koizumi Y, Oka K, Yamagishi Y, Takahashi M, Mikamo H. Clostridium butyricum Modulates the Microbiome to Protect Intestinal Barrier Function in Mice with Antibiotic-Induced Dysbiosis. iScience 2020;23:100772. [PMID: 31954979 DOI: 10.1016/j.isci.2019.100772] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 6.0] [Reference Citation Analysis]
33 Duan J, Song Y, Zhang X, Wang C. Effect of ω-3 Polyunsaturated Fatty Acids-Derived Bioactive Lipids on Metabolic Disorders. Front Physiol 2021;12:646491. [PMID: 34113260 DOI: 10.3389/fphys.2021.646491] [Reference Citation Analysis]
34 Liu G, Gong Y, Zhang R, Piao L, Li X, Liu Q, Yan S, Shen Y, Guo S, Zhu M, Yin H, Funk CD, Zhang J, Yu Y. Resolvin E1 attenuates inj ury‐induced vascular neointimal formation by inhibition of inflammatory responses and vascular smooth muscle cell migration. FASEB j 2018;32:5413-25. [DOI: 10.1096/fj.201800173r] [Cited by in Crossref: 23] [Cited by in F6Publishing: 16] [Article Influence: 5.8] [Reference Citation Analysis]
35 Barnig C, Bezema T, Calder PC, Charloux A, Frossard N, Garssen J, Haworth O, Dilevskaya K, Levi-Schaffer F, Lonsdorfer E, Wauben M, Kraneveld AD, Te Velde AA. Activation of Resolution Pathways to Prevent and Fight Chronic Inflammation: Lessons From Asthma and Inflammatory Bowel Disease. Front Immunol 2019;10:1699. [PMID: 31396220 DOI: 10.3389/fimmu.2019.01699] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 7.0] [Reference Citation Analysis]
36 Irún P, Lanas A, Piazuelo E. Omega-3 Polyunsaturated Fatty Acids and Their Bioactive Metabolites in Gastrointestinal Malignancies Related to Unresolved Inflammation. A Review. Front Pharmacol 2019;10:852. [PMID: 31427966 DOI: 10.3389/fphar.2019.00852] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 4.7] [Reference Citation Analysis]
37 Quiros M, Feier D, Birkl D, Agarwal R, Zhou DW, García AJ, Parkos CA, Nusrat A. Resolvin E1 is a pro-repair molecule that promotes intestinal epithelial wound healing. Proc Natl Acad Sci U S A 2020;117:9477-82. [PMID: 32300016 DOI: 10.1073/pnas.1921335117] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 9.5] [Reference Citation Analysis]
38 Hirata SI, Nagatake T, Sawane K, Hosomi K, Honda T, Ono S, Shibuya N, Saito E, Adachi J, Abe Y, Isoyama J, Suzuki H, Matsunaga A, Tomonaga T, Kiyono H, Kabashima K, Arita M, Kunisawa J. Maternal ω3 docosapentaenoic acid inhibits infant allergic dermatitis through TRAIL-expressing plasmacytoid dendritic cells in mice. Allergy 2020;75:1939-55. [PMID: 32027039 DOI: 10.1111/all.14217] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
39 Giacobbe J, Benoiton B, Zunszain P, Pariante CM, Borsini A. The Anti-Inflammatory Role of Omega-3 Polyunsaturated Fatty Acids Metabolites in Pre-Clinical Models of Psychiatric, Neurodegenerative, and Neurological Disorders. Front Psychiatry 2020;11:122. [PMID: 32180741 DOI: 10.3389/fpsyt.2020.00122] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 10.0] [Reference Citation Analysis]
40 Nagatake T, Kunisawa J. Emerging roles of metabolites of ω3 and ω6 essential fatty acids in the control of intestinal inflammation. Int Immunol 2019;31:569-77. [PMID: 30722032 DOI: 10.1093/intimm/dxy086] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
41 Dalli J, Gomez EA, Jouvene CC. Utility of the Specialized Pro-Resolving Mediators as Diagnostic and Prognostic Biomarkers in Disease. Biomolecules 2022;12:353. [DOI: 10.3390/biom12030353] [Reference Citation Analysis]
42 Quiros M, Nusrat A. Saving Problematic Mucosae: SPMs in Intestinal Mucosal Inflammation and Repair. Trends Mol Med 2019;25:124-35. [PMID: 30642681 DOI: 10.1016/j.molmed.2018.12.004] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
43 Flak MB, Koenis DS, Sobrino A, Smith J, Pistorius K, Palmas F, Dalli J. GPR101 mediates the pro-resolving actions of RvD5n-3 DPA in arthritis and infections. J Clin Invest 2020;130:359-73. [PMID: 31793912 DOI: 10.1172/JCI131609] [Cited by in Crossref: 21] [Cited by in F6Publishing: 14] [Article Influence: 10.5] [Reference Citation Analysis]
44 Margină D, Ungurianu A, Purdel C, Nițulescu GM, Tsoukalas D, Sarandi E, Thanasoula M, Burykina TI, Tekos F, Buha A, Nikitovic D, Kouretas D, Tsatsakis AM. Analysis of the intricate effects of polyunsaturated fatty acids and polyphenols on inflammatory pathways in health and disease. Food Chem Toxicol 2020;143:111558. [PMID: 32640331 DOI: 10.1016/j.fct.2020.111558] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 7.0] [Reference Citation Analysis]
45 Prevete N, Liotti F, Amoresano A, Pucci P, de Paulis A, Melillo RM. New perspectives in cancer: Modulation of lipid metabolism and inflammation resolution. Pharmacological Research 2018;128:80-7. [DOI: 10.1016/j.phrs.2017.09.024] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 4.3] [Reference Citation Analysis]
46 Määttänen P, Lurz E, Botts SR, Wu RY, Robinson SC, Yeung CW, Colas R, Li B, Johnson-Henry KC, Surette ME, Dalli J, Sherman PM. Plant- and Fish-Derived n-3 PUFAs Suppress Citrobacter Rodentium-Induced Colonic Inflammation. Mol Nutr Food Res 2020;64:e1900873. [PMID: 31945799 DOI: 10.1002/mnfr.201900873] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
47 Pascoal LB, Palma BB, Chaim FHM, de Castro MM, Damázio TA, Franceschini APMF, Milanski M, Velloso LA, Leal RF. New translational and experimental insights into the role of pro-resolving lipid mediators in inflammatory bowel disease. World J Exp Med 2022; 12(1): 1-15 [DOI: 10.5493/wjem.v12.i1.1] [Reference Citation Analysis]
48 Livshits G, Kalinkovich A. Receptors for pro-resolving mediators as a therapeutic tool for smooth muscle remodeling-associated disorders. Pharmacol Res 2021;164:105340. [PMID: 33276103 DOI: 10.1016/j.phrs.2020.105340] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
49 Sitkin S, Pokrotnieks J. Alterations in Polyunsaturated Fatty Acid Metabolism and Reduced Serum Eicosadienoic Acid Level in Ulcerative Colitis: Is There a Place for Metabolomic Fatty Acid Biomarkers in IBD? Dig Dis Sci 2018;63:2480-1. [PMID: 29987625 DOI: 10.1007/s10620-018-5182-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
50 Fishbein A, Hammock BD, Serhan CN, Panigrahy D. Carcinogenesis: Failure of resolution of inflammation? Pharmacol Ther 2021;218:107670. [PMID: 32891711 DOI: 10.1016/j.pharmthera.2020.107670] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 9.0] [Reference Citation Analysis]
51 Sun X, Yao L, Liang H, Wang D, He Y, Wei Y, Ye L, Wang K, Li L, Chen J, Zhang CY, Xu G, Wang F, Zen K. Intestinal epithelial PKM2 serves as a safeguard against experimental colitis via activating β-catenin signaling. Mucosal Immunol 2019;12:1280-90. [PMID: 31462699 DOI: 10.1038/s41385-019-0197-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
52 Makino Y, Miyahara T, Nitta J, Miyahara K, Seo A, Kimura M, Suhara M, Akai A, Akagi D, Yamamoto K, Hoshina K. Proresolving Lipid Mediators Resolvin D1 and Protectin D1 Isomer Attenuate Neointimal Hyperplasia in the Rat Carotid Artery Balloon Injury Model. Journal of Surgical Research 2019;233:104-10. [DOI: 10.1016/j.jss.2018.07.049] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
53 Ma C, Vasu R, Zhang H. The Role of Long-Chain Fatty Acids in Inflammatory Bowel Disease. Mediators Inflamm 2019;2019:8495913. [PMID: 31780872 DOI: 10.1155/2019/8495913] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
54 Kim SE, Lee J, An JU, Kim TH, Oh CW, Ko YJ, Krishnan M, Choi J, Yoon DY, Kim Y, Oh DK. Regioselectivity of an arachidonate 9S-lipoxygenase from Sphingopyxis macrogoltabida that biosynthesizes 9S,15S- and 11S,17S-dihydroxy fatty acids from C20 and C22 polyunsaturated fatty acids. Biochim Biophys Acta Mol Cell Biol Lipids 2021;1867:159091. [PMID: 34902567 DOI: 10.1016/j.bbalip.2021.159091] [Reference Citation Analysis]
55 Duarte LRF, Pinho V, Rezende BM, Teixeira MM. Resolution of Inflammation in Acute Graft-Versus-Host-Disease: Advances and Perspectives. Biomolecules 2022;12:75. [DOI: 10.3390/biom12010075] [Reference Citation Analysis]
56 Bertoni S, Ballabeni V, Barocelli E, Tognolini M. Mesenteric ischemia-reperfusion: an overview of preclinical drug strategies. Drug Discovery Today 2018;23:1416-25. [DOI: 10.1016/j.drudis.2018.05.034] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
57 Trilleaud C, Gauttier V, Biteau K, Girault I, Belarif L, Mary C, Pengam S, Teppaz G, Thepenier V, Danger R, Robert-Siegwald G, Néel M, Bruneau S, Glémain A, Néel A, Poupon A, Mosnier JF, Chêne G, Dubourdeau M, Blancho G, Vanhove B, Poirier N. Agonist anti-ChemR23 mAb reduces tissue neutrophil accumulation and triggers chronic inflammation resolution. Sci Adv 2021;7:eabd1453. [PMID: 33811066 DOI: 10.1126/sciadv.abd1453] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
58 Serhan CN, Levy BD. Resolvins in inflammation: emergence of the pro-resolving superfamily of mediators. J Clin Invest 2018;128:2657-69. [PMID: 29757195 DOI: 10.1172/JCI97943] [Cited by in Crossref: 410] [Cited by in F6Publishing: 250] [Article Influence: 102.5] [Reference Citation Analysis]
59 Du Y, Taylor CG, Aukema HM, Zahradka P. Role of oxylipins generated from dietary PUFAs in the modulation of endothelial cell function. Prostaglandins, Leukotrienes and Essential Fatty Acids 2020;160:102160. [DOI: 10.1016/j.plefa.2020.102160] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
60 Dalli J, Pistorius K, Walker ME. Novel n-3 Docosapentaneoic Acid-Derived Pro-resolving Mediators Are Vasculoprotective and Mediate the Actions of Statins in Controlling Inflammation. In: Honn KV, Zeldin DC, editors. The Role of Bioactive Lipids in Cancer, Inflammation and Related Diseases. Cham: Springer International Publishing; 2019. pp. 65-75. [DOI: 10.1007/978-3-030-21735-8_7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
61 Ahluwalia K, Ebright B, Chow K, Dave P, Mead A, Poblete R, Louie SG, Asante I. Lipidomics in Understanding Pathophysiology and Pharmacologic Effects in Inflammatory Diseases: Considerations for Drug Development. Metabolites 2022;12:333. [DOI: 10.3390/metabo12040333] [Reference Citation Analysis]
62 Wu Z, Lu G, Zhang L, Ke L, Yuan C, Ma N, Yu X, Guo X, Zhao W, Wang Y, Hu S, Wu D, Li W. Protectin D1 decreases pancreatitis severity in mice by inhibiting neutrophil extracellular trap formation. Int Immunopharmacol 2021;94:107486. [PMID: 33639566 DOI: 10.1016/j.intimp.2021.107486] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
63 Ariyoshi T, Hagihara M, Eguchi S, Fukuda A, Iwasaki K, Oka K, Takahashi M, Yamagishi Y, Mikamo H. Clostridium butyricum MIYAIRI 588-Induced Protectin D1 Has an Anti-inflammatory Effect on Antibiotic-Induced Intestinal Disorder. Front Microbiol 2020;11:587725. [PMID: 33193245 DOI: 10.3389/fmicb.2020.587725] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
64 Dalli J, Serhan CN. Identification and structure elucidation of the pro-resolving mediators provides novel leads for resolution pharmacology. Br J Pharmacol 2019;176:1024-37. [PMID: 29679485 DOI: 10.1111/bph.14336] [Cited by in Crossref: 57] [Cited by in F6Publishing: 57] [Article Influence: 14.3] [Reference Citation Analysis]
65 Na YR, Stakenborg M, Seok SH, Matteoli G. Macrophages in intestinal inflammation and resolution: a potential therapeutic target in IBD. Nat Rev Gastroenterol Hepatol. 2019;16:531-543. [PMID: 31312042 DOI: 10.1038/s41575-019-0172-4] [Cited by in Crossref: 142] [Cited by in F6Publishing: 141] [Article Influence: 47.3] [Reference Citation Analysis]
66 Pistol GC, Bulgaru CV, Marin DE, Oancea AG, Taranu I. Dietary Grape Seed Meal Bioactive Compounds Alleviate Epithelial Dysfunctions and Attenuates Inflammation in Colon of DSS-Treated Piglets. Foods 2021;10:530. [PMID: 33806347 DOI: 10.3390/foods10030530] [Reference Citation Analysis]
67 Drouin G, Rioux V, Legrand P. The n-3 docosapentaenoic acid (DPA): A new player in the n-3 long chain polyunsaturated fatty acid family. Biochimie 2019;159:36-48. [DOI: 10.1016/j.biochi.2019.01.022] [Cited by in Crossref: 42] [Cited by in F6Publishing: 32] [Article Influence: 14.0] [Reference Citation Analysis]
68 Recchiuti A, Mattoscio D, Isopi E. Roles, Actions, and Therapeutic Potential of Specialized Pro-resolving Lipid Mediators for the Treatment of Inflammation in Cystic Fibrosis. Front Pharmacol 2019;10:252. [PMID: 31001110 DOI: 10.3389/fphar.2019.00252] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 6.3] [Reference Citation Analysis]
69 Jonasdottir HS, Brouwers H, Toes REM, Ioan-Facsinay A, Giera M. Effects of anticoagulants and storage conditions on clinical oxylipid levels in human plasma. Biochim Biophys Acta Mol Cell Biol Lipids 2018;1863:1511-22. [PMID: 30308322 DOI: 10.1016/j.bbalip.2018.10.003] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 6.0] [Reference Citation Analysis]
70 Baptista LC, Sun Y, Carter CS, Buford TW. Crosstalk Between the Gut Microbiome and Bioactive Lipids: Therapeutic Targets in Cognitive Frailty. Front Nutr 2020;7:17. [PMID: 32219095 DOI: 10.3389/fnut.2020.00017] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
71 Chiang N, Serhan CN. Specialized pro-resolving mediator network: an update on production and actions. Essays Biochem 2020;64:443-62. [PMID: 32885825 DOI: 10.1042/EBC20200018] [Cited by in Crossref: 27] [Cited by in F6Publishing: 15] [Article Influence: 13.5] [Reference Citation Analysis]
72 Rosenthal MD, Patel J, Staton K, Martindale RG, Moore FA, Upchurch GR Jr. Can Specialized Pro-resolving Mediators Deliver Benefit Originally Expected from Fish Oil? Curr Gastroenterol Rep 2018;20:40. [PMID: 30078085 DOI: 10.1007/s11894-018-0647-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
73 Primdahl KG, Tungen JE, De Souza PRS, Colas RA, Dalli J, Hansen TV, Vik A. Stereocontrolled synthesis and investigation of the biosynthetic transformations of 16(S),17(S)-epoxy-PD n-3 DPA. Org Biomol Chem 2017;15:8606-13. [DOI: 10.1039/c7ob02113e] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
74 Pangopoulos MK, Nolsøe JMN, Antonsen SG, Colas RA, Dalli J, Aursnes M, Stenstrøm Y, Hansen TV. Enzymatic studies with 3-oxa n-3 DPA. Bioorg Chem 2020;96:103653. [PMID: 32062066 DOI: 10.1016/j.bioorg.2020.103653] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
75 Leuti A, Fazio D, Fava M, Piccoli A, Oddi S, Maccarrone M. Bioactive lipids, inflammation and chronic diseases. Adv Drug Deliv Rev 2020;159:133-69. [PMID: 32628989 DOI: 10.1016/j.addr.2020.06.028] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 10.0] [Reference Citation Analysis]
76 Romano M, Patruno S, Pomilio A, Recchiuti A. Proresolving Lipid Mediators and Receptors in Stem Cell Biology: Concise Review. Stem Cells Transl Med 2019;8:992-8. [PMID: 31187940 DOI: 10.1002/sctm.19-0078] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
77 Stoeva MK, Garcia-So J, Justice N, Myers J, Tyagi S, Nemchek M, McMurdie PJ, Kolterman O, Eid J. Butyrate-producing human gut symbiont, Clostridium butyricum, and its role in health and disease. Gut Microbes 2021;13:1-28. [PMID: 33874858 DOI: 10.1080/19490976.2021.1907272] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
78 Mikroulis A, Ledri M, Ruffolo G, Palma E, Sperk G, Dalli J, Vezzani A, Kokaia M. Lipid mediator n-3 docosapentaenoic acid-derived protectin D1 enhances synaptic inhibition of hippocampal principal neurons by interaction with a G-protein-coupled receptor. FASEB J 2022;36:e22203. [PMID: 35188290 DOI: 10.1096/fj.202101815R] [Reference Citation Analysis]
79 Neurath MF, Leppkes M. Resolution of ulcerative colitis. Semin Immunopathol 2019;41:747-56. [DOI: 10.1007/s00281-019-00751-6] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 5.7] [Reference Citation Analysis]
80 Hansen TV, Vik A, Serhan CN. The Protectin Family of Specialized Pro-resolving Mediators: Potent Immunoresolvents Enabling Innovative Approaches to Target Obesity and Diabetes. Front Pharmacol 2018;9:1582. [PMID: 30705632 DOI: 10.3389/fphar.2018.01582] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 12.0] [Reference Citation Analysis]
81 Vanzant E, Loftus T, Kamel A, Carmichael E, Rosenthal MD. Nutritional impact of omega 3 fatty acids and metabolites in acute and chronic critical illness. Curr Opin Clin Nutr Metab Care 2022;25:75-80. [PMID: 35115447 DOI: 10.1097/MCO.0000000000000818] [Reference Citation Analysis]
82 Ganesan R, Henkels KM, Shah K, De La Rosa X, Libreros S, Cheemarla NR, Serhan CN, Gomez-Cambronero J. D-series Resolvins activate Phospholipase D in phagocytes during inflammation and resolution. FASEB J 2020;34:15888-906. [PMID: 33047359 DOI: 10.1096/fj.201903025RR] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
83 Bamias G, Arseneau KO, Cominelli F. Mouse models of inflammatory bowel disease for investigating mucosal immunity in the intestine. Curr Opin Gastroenterol 2017;33:411-6. [PMID: 28901966 DOI: 10.1097/MOG.0000000000000402] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 4.3] [Reference Citation Analysis]
84 Rohwer N, Chiu CY, Huang D, Smyl C, Rothe M, Rund KM, Helge Schebb N, Kühn H, Weylandt KH. Omega-3 fatty acids protect from colitis via an Alox15-derived eicosanoid. FASEB J 2021;35:e21491. [PMID: 33710695 DOI: 10.1096/fj.202002340RR] [Reference Citation Analysis]
85 Hansen TV, Dalli J, Serhan CN. The novel lipid mediator PD1n-3 DPA: An overview of the structural elucidation, synthesis, biosynthesis and bioactions. Prostaglandins Other Lipid Mediat 2017;133:103-10. [PMID: 28602942 DOI: 10.1016/j.prostaglandins.2017.06.003] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 5.4] [Reference Citation Analysis]
86 Dawson HD, Chen C, Li RW, Bell LN, Shea-Donohue T, Kringel H, Beshah E, Hill DE, Urban JF Jr. Molecular and metabolomic changes in the proximal colon of pigs infected with Trichuris suis. Sci Rep 2020;10:12853. [PMID: 32732949 DOI: 10.1038/s41598-020-69462-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
87 Caprara G, Allavena P, Erreni M. Intestinal Macrophages at the Crossroad between Diet, Inflammation, and Cancer. Int J Mol Sci 2020;21:E4825. [PMID: 32650452 DOI: 10.3390/ijms21144825] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
88 Ariyoshi T, Hagihara M, Tomono S, Eguchi S, Minemura A, Miura D, Oka K, Takahashi M, Yamagishi Y, Mikamo H. Clostridium butyricum MIYAIRI 588 Modifies Bacterial Composition under Antibiotic-Induced Dysbiosis for the Activation of Interactions via Lipid Metabolism between the Gut Microbiome and the Host. Biomedicines 2021;9:1065. [PMID: 34440269 DOI: 10.3390/biomedicines9081065] [Reference Citation Analysis]
89 Motwani MP, Colas RA, George MJ, Flint JD, Dalli J, Richard-Loendt A, De Maeyer RP, Serhan CN, Gilroy DW. Pro-resolving mediators promote resolution in a human skin model of UV-killed Escherichia coli-driven acute inflammation. JCI Insight 2018;3:94463. [PMID: 29563331 DOI: 10.1172/jci.insight.94463] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 8.3] [Reference Citation Analysis]